Amkay Products (BOM:544169) EBITDA per Share: ₹5.33 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544169 Amkay Products Ltd BOM:544169
36 GF Score
Price ₹43.00
! 2 Warning Signs
View Full Analysis

What is Amkay Products EBITDA per Share?

Amkay Products BOM:544169 36 EBITDA per Share is ₹5.33 as of Mar. 2026. GuruFocus rates BOM:544169 with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 690 Medical Devices & Instruments companies, Amkay Products ranks better than 50.43% on this metric.

Amkay Products's EBITDA per Share for the six months ended in Mar. 2026 was ₹1.34. Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.33.

During the past 12 months, the average EBITDA per Share Growth Rate of Amkay Products was -19.20% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 8.80% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Amkay Products's EBITDA per Share or its related term are showing as below:

BOM:544169' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -0.6   Med: 8.8   Max: 23.7
Current: 8.8

During the past 6 years, the highest 3-Year average EBITDA per Share Growth Rate of Amkay Products was 23.70% per year. The lowest was -0.60% per year. And the median was 8.80% per year.

BOM:544169's 3-Year EBITDA Growth Rate is ranked better than
50.43% of 690 companies
in the Medical Devices & Instruments industry
Industry Median: 8.2 vs BOM:544169: 8.80

Amkay Products's EBITDA for the six months ended in Mar. 2026 was ₹11.5 Mil.

During the past 12 months, the average EBITDA Growth Rate of Amkay Products was -17.10% per year. During the past 3 years, the average EBITDA Growth Rate was 8.80% per year. During the past 5 years, the average EBITDA Growth Rate was 5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 6 years, the highest 3-Year average EBITDA Growth Rate of Amkay Products was 22.60% per year. The lowest was -0.60% per year. And the median was 8.80% per year.


Amkay Products  (BOM:544169) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Amkay Products EBITDA per Share Related Terms


Amkay Products EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Amkay Products's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amkay Products EBITDA per Share Chart

Amkay Products Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA per Share
Get a 7-Day Free Trial 3.42 4.06 5.23 6.46 5.22

Amkay Products Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBITDA per Share Get a 7-Day Free Trial Premium Member Only 2.61 3.83 2.64 3.99 1.34
BOM:544169
36GF Score
Amkay Products Ltd BOM:544169
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amkay Products EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Amkay Products's EBITDA per Share for the fiscal year that ended in Mar. 2026 is calculated as

EBITDA per Share(A: Mar. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=45.168/8.655
=5.22

Amkay Products's EBITDA per Share for the quarter that ended in Mar. 2026 is calculated as

EBITDA per Share(Q: Mar. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=11.489/8.575
=1.34

EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹5.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of ₹5.33 mean?
Amkay Products (BOM:544169) has a EBITDA per Share of ₹5.33 as of Mar. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Amkay Products and its competitors. According to the industry distribution chart, Amkay Products ranks #342 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 49.6%.
Is Amkay Products' EBITDA per Share too high?
Amkay Products' current EBITDA per Share is ₹5.33. Based on the distribution chart, Amkay Products ranks #342 out of 690 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Amkay Products has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Amkay Products' EBITDA per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Amkay Products ranks #342 out of 690 companies for EBITDA per Share. This puts Amkay Products in the upper half of its industry. The industry median EBITDA per Share is 8.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Medical Devices & Instruments company?
The median EBITDA per Share among Medical Devices & Instruments companies is 8.20, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Amkay Products and its competitors. For the Medical Devices & Instruments industry, the median EBITDA per Share is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amkay Products's current EBITDA per Share is ₹5.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amkay Products stock overvalued right now?
Amkay Products (BOM:544169) has a current EBITDA per Share of ₹5.33. The current EBITDA per Share is ₹5.33. Amkay Products' overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Amkay Products (BOM:544169), the current EBITDA per Share is ₹5.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amkay Products Business Description

Address Waliv Road, Bunglow No. 68, Rashmi Park CHS Ltd, Dhumal Nagar, Taluka Vasai, Vasai (East) Thane, Palghar, MH, IND, 401208
Amkay Products Ltd is a healthcare company. It manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. Additionally, engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc.
36GF Score

Get the complete analysis for BOM:544169

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹43.00
Price